Newsletters

Dear All, I wrote in the 19 Feb 2025 newsletter about HERA’s 13m EUR call for rapid point-of-care susceptibility devices. The

Dear All, Two quick updates this evening. First, you will recall that CARB-X have announced their initial 2025 funding round

Dear All (and with thanks to Patricia Bradford for taking the lead on this newsletter): Today, this paper in Nature

Dear All, At BEAM’s AMR Conference in Basel, Team CARB-X have today announced their 2025 funding round. Key points: Two

Dear All, I have learned that the Ineos Oxford Institute for Antimicrobial Research (IOI) has started a job search for

24 Mar 2025 update: The call is live! It’s entitled “Development of a Rapid Point-of-care Antimicrobial Susceptibility Testing Diagnostic Medical

Dear All, EMA have recently posted a call for tenders under which they seek to “procure the services of research

Dear All, The Advisory Committee on Immunization Practices (ACIP) is scheduled to meet 26-28 Feb 2025 (see links below my signature

Dear All, If you are attending ESCMID Global in Vienna this year, mark your calendar for two major events. I

Dear All, A huge announcement today backed by the combined power of the Gates Foundation, Novo Nordisk, and Wellcome! I

Dear All, Sadly, I must report that the 27th meeting of PACCARB (the US Presidential Advisory Council on Combatting Antibiotic-Resistant

Dear All, Three things for today along with some great acronyms! To start, we have an announcement of the first

Dear All (and with thanks to Damiano for taking the lead on this newsletter), We start the new year with good

Dear All, I wrote in the 1 Dec 2024 newsletter about the excellent paper by Baraldi et al. that introduced

Dear All, I’ve written before about the Vivli AMR Surveillance Data Challenge that seeks creative ways to reuse MICs from surveillance

Dear All, Just released, the 2026 NIAID DMID Omnibus Broad Agency Announcement (HHS-NIH-NIAID-BAA2025-1) seeks applications for projects to treat, prevent,